These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3220617

  • 1. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
    Garg SK, Dhand R, Malik SK, Kalra S, Gupta PH, Jha VK, Shukla VK, Lal R.
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
    [Abstract] [Full Text] [Related]

  • 2. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S, Singh I, Kaur KJ, Bhade SR, Kaul CL, Panchagnula R.
    Int J Pharm; 2004 May 19; 276(1-2):41-9. PubMed ID: 15113612
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
    Pilheu JA, Galati MR, Yunis AS, De Salvo MC, Negroni R, García Fernández JC, Mingolla L, Rubio MC, Masana M, Acevedo C.
    Medicina (B Aires); 1989 May 19; 49(1):43-7. PubMed ID: 2698437
    [Abstract] [Full Text] [Related]

  • 4. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
    Zwolska Z, Augustynowicz-Kopeć E, Niemirowska-Mikulska H.
    Acta Pol Pharm; 2002 May 19; 59(6):448-52. PubMed ID: 12669769
    [Abstract] [Full Text] [Related]

  • 5. [Adjusting or not adjusting isoniazid dosage?].
    Parrot R, Boval C, Grosset J, Gaillard JP.
    Rev Fr Mal Respir; 1983 May 19; 11(5):705-12. PubMed ID: 6658156
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E, Azuaje C, Lopez RM, Domingo P, Curran A, Feijoo M, Pou L, Sánchez P, Sambeat MA, Colomer J, Lopez-Colomes JL, Crespo M, Falcó V, Ocaña I, Pahissa A.
    J Antimicrob Chemother; 2007 Apr 19; 59(4):690-7. PubMed ID: 17307771
    [Abstract] [Full Text] [Related]

  • 7. [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
    Loos U, Musch E, Schwabe HK.
    Pneumologie; 1990 Feb 19; 44 Suppl 1():488-9. PubMed ID: 2367445
    [Abstract] [Full Text] [Related]

  • 8. Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis.
    Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, Swaminathan S, Venkatesan P, Sekar L, Kumar S, Krishnarajasekhar OR, Paramesh P.
    Clin Infect Dis; 2004 Jan 15; 38(2):280-3. PubMed ID: 14699462
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy.
    Acocella G, Luisetti M, Grassi GG, Peona V, Pozzi E, Grassi C.
    Monaldi Arch Chest Dis; 1993 Jan 15; 48(3):205-9. PubMed ID: 8369784
    [Abstract] [Full Text] [Related]

  • 10. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
    Karkishchenko NN, Khoron'ko VV, Vorob'ev VS, Anisimova NB, Chubarian VT.
    Probl Tuberk; 1987 Jan 15; (9):31-4. PubMed ID: 3422964
    [No Abstract] [Full Text] [Related]

  • 11. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
    Zwolska Z, Niemirowska-Mikulska H, Augustynowicz-Kopec E, Walkiewicz R, Stambrowska H, Safianowska A, Grubek-Jaworska H.
    Int J Tuberc Lung Dis; 1998 Oct 15; 2(10):824-30. PubMed ID: 9783530
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
    Roy V, Tekur U, Chopra K.
    Indian Pediatr; 1996 Apr 15; 33(4):287-91. PubMed ID: 8772902
    [Abstract] [Full Text] [Related]

  • 13. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E, Ordronneau J, Le Normand Y, Kergueris MF, Larousse C.
    Rev Fr Mal Respir; 1980 Apr 15; 8(3):219-24. PubMed ID: 7187065
    [Abstract] [Full Text] [Related]

  • 14. [Results of examination in healthy volunteers of rifampicin and isoniazid bioavailability from Polish two-drug combination capsules of rifamazid used for tuberculosis treatment].
    Zofia Z, Niemirowska-Mikulska H, Augustynowicz-Kopeć E, Stambrowska A.
    Pneumonol Alergol Pol; 1998 Apr 15; 66(3-4):198-206. PubMed ID: 9857665
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
    Gurumurthy P, Ramachandran G, Vijayalakshmi S, Kumar AK, Venkatesan P, Chandrasekaran V, Vjayasekaran V, Kumaraswami V, Prabhakar R.
    Int J Tuberc Lung Dis; 1999 Feb 15; 3(2):119-25. PubMed ID: 10091876
    [Abstract] [Full Text] [Related]

  • 16. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A, Bergogne-Berezin E, Lafaix C.
    Pathol Biol (Paris); 1982 Jun 15; 30(6):389-93. PubMed ID: 7050848
    [Abstract] [Full Text] [Related]

  • 17. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
    Panchagnula R, Singh I, Kaur KJ, Kaul CL.
    Methods Find Exp Clin Pharmacol; 1999 Nov 15; 21(9):625-8. PubMed ID: 10669909
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of rifampicin and isoniazid in tuberculosis.
    Seth V, Beotra A, Seth SD, Semwal OP, Kabra S, Jain Y, Mukhopadhya S.
    Indian Pediatr; 1993 Sep 15; 30(9):1091-8. PubMed ID: 8125594
    [Abstract] [Full Text] [Related]

  • 19. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC, Rathi R, Kishore K, Varshney SC, Varshney DP.
    Indian J Physiol Pharmacol; 1986 Sep 15; 30(1):115-7. PubMed ID: 3818028
    [No Abstract] [Full Text] [Related]

  • 20. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
    Knop P, Kindler U, Austerhoff A.
    Dtsch Med Wochenschr; 1977 Dec 30; 102(52):1913-5. PubMed ID: 598300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.